Clinical trial
Effect of Intravitreal Injection of Aflibercept on Blood Coagulation Parameters in Patients With Age Related Macular Degeneration
NCT03509623 is registered in ClinicalTrials.gov with University Hospital of Patras as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Intravitreal Injection of Aflibercept on Blood Coagulation Parameters in Patients With Age Related Macular Degeneration
- Lead sponsor
- University Hospital of Patras
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 2, 2017
- Completion date
- April 27, 2018
- Enrollment
- 47 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neovascular age-related macular degeneration